XML 56 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
SELECTED FINANCIAL STATEMENT INFORMATION
9 Months Ended
Jul. 31, 2014
Selected Financial Statement Information [Abstract]  
Selected Financial Statement Information [Text Block]
SELECTED FINANCIAL STATEMENT INFORMATION

Accounts Receivable
(in thousands)
 
July 31, 2014
 
October 31, 2013
Accounts receivable
 

$151,504

 

$160,118

Less: Allowance for doubtful accounts
 
(2,344
)
 
(3,096
)
Accounts receivable, net
 

$149,160

 

$157,022



Costs and Estimated Earnings on Uncompleted Percentage-of-Completion Contracts
(in thousands)
 
July 31, 2014
 
October 31, 2013
Costs incurred on uncompleted contracts
 

$28,198

 

$22,548

Estimated earnings
 
14,605

 
25,391

 
 
42,803

 
47,939

Less: Billings to date
 
(37,305
)
 
(40,676
)


 

$5,498

 

$7,263

Included in the accompanying Condensed Consolidated Balance Sheets under the following captions:
 
 
 
 
Accounts receivable, net (costs and estimated earnings in excess of billings)
 

$7,469

 

$9,540

Accrued expenses and other current liabilities (billings in excess of costs and estimated earnings)
 
(1,971
)
 
(2,277
)
 
 

$5,498

 

$7,263



Changes in estimates pertaining to percentage-of-completion contracts did not have a material effect on net income from consolidated operations for the nine and three months ended July 31, 2014 and 2013.
Inventories
(in thousands)
 
July 31, 2014
 
October 31, 2013
Finished products
 

$108,072

 

$103,234

Work in process
 
29,057

 
26,810

Materials, parts, assemblies and supplies
 
80,135

 
79,863

Contracts in process
 
3,865

 
9,941

Less: Billings to date
 

 
(955
)
Inventories, net of valuation reserves
 

$221,129

 

$218,893


Contracts in process represents accumulated capitalized costs associated with fixed price contracts for which revenue is recognized on the completed-contract method. Related progress billings and customer advances (“billings to date”) are classified as a reduction to contracts in process, if any, and any excess is included in accrued expenses and other current liabilities.

Property, Plant and Equipment
(in thousands)
 
July 31, 2014
 
October 31, 2013
Land
 

$4,510

 

$4,515

Buildings and improvements
 
60,547

 
60,105

Machinery, equipment and tooling
 
140,659

 
131,855

Construction in progress
 
5,843

 
4,932

 
 
211,559

 
201,407

Less: Accumulated depreciation and amortization
 
(116,429
)
 
(103,670
)
Property, plant and equipment, net
 

$95,130

 

$97,737



Accrued Customer Rebates and Credits

The aggregate amount of accrued customer rebates and credits included within accrued expenses and other current liabilities in the accompanying Condensed Consolidated Balance Sheets was $8.8 million and $14.8 million as of July 31, 2014 and October 31, 2013, respectively. The total customer rebates and credits deducted within net sales for the nine months ended July 31, 2014 and 2013 was $5.3 million and $6.0 million, respectively. The total customer rebates and credits deducted within net sales for the three months ended July 31, 2014 and 2013 was $1.9 million and $2.5 million, respectively. The decrease in the amount of accrued customer rebates and credits since October 31, 2013 principally reflects the payments made in the second quarter of fiscal 2014.

Employee Retirement Plan

In connection with an acquisition during the third quarter of fiscal 2013, the Company assumed a frozen qualified defined benefit pension plan. The components of net pension income for the nine and three months ended July 31, 2014 and 2013 that were recorded within the Company's Condensed Consolidated Statements of Operations are as follows (in thousands):
 
 
Nine months ended July 31,
 
Three months ended July 31,
 
 
2014
 
2013
 
2014
 
2013
Expected return on plan assets
 

$555

 

$128

 

$185

 

$128

Interest cost
 
459

 
95

 
153

 
95

Net pension income
 

$96

 

$33

 

$32

 

$33




Research and Development Expenses

The amount of new product research and development expenses (R&D expenses) included in costs of sales for the nine and three months ended July 31, 2014 and 2013 is as follows (in thousands):
 
 
Nine months ended July 31,
 
Three months ended July 31,
 
 
2014
 
2013
 
2014
 
2013
R&D expenses
 

$28,278

 

$23,547

 

$9,862

 

$8,550



Redeemable Noncontrolling Interests

The holders of equity interests in certain of the Company's subsidiaries have put rights that may be exercised on varying dates causing the Company to give cash consideration to purchase their equity interests based on fair value or a formula that management intended to reasonably approximate fair value based solely on a multiple of future earnings over a measurement period. Management's estimate of the aggregate redemption amount of all put rights that the Company could be required to pay at varying dates through fiscal 2022 is as follows (in thousands):
 
 
July 31, 2014
 
October 31, 2013
Redeemable at fair value
 

$27,969

 

$47,839

Redeemable based on a multiple of future earnings
 
10,136

 
11,379

Redeemable noncontrolling interests
 

$38,105

 

$59,218



The decrease in the aggregate redemption amount of put rights redeemable at fair value since the prior fiscal year end principally reflects a reclassification of the redemption amount pertaining to the equity interest in one of the Company's subsidiaries from redeemable noncontrolling interests (temporary equity) to noncontrolling interests (permanent equity) upon the expiration of the holder's put right in the second quarter of fiscal 2014.

Accumulated Other Comprehensive Income (Loss)

Changes in the components of accumulated other comprehensive income (loss) for the nine months ended July 31, 2014 are as follows (in thousands):
 
 
Foreign Currency Translation
 
Pension Benefit Obligation
 
Accumulated
Other Comprehensive
Income (Loss)
Balances at October 31, 2013
 

($466
)
 

$610

 

$144

Unrealized loss
 
(2,715
)
 

 
(2,715
)
Balances at July 31, 2014
 

($3,181
)
 

$610

 

($2,571
)